These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 6701373)
1. Detection bias in mammographic screening for breast carcinoma. Andersson I Recent Results Cancer Res; 1984; 90():164-5. PubMed ID: 6701373 [No Abstract] [Full Text] [Related]
2. Breast cancer screening with mammography: a population-based, randomized trial with mammography as the only screening mode. Andersson I; Andrén L; Hildell J; Linell F; Ljungqvist U; Pettersson H Radiology; 1979 Aug; 132(2):273-6. PubMed ID: 461778 [TBL] [Abstract][Full Text] [Related]
4. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737 [TBL] [Abstract][Full Text] [Related]
5. Detecting which invasive cancers at mammographic screening saves lives? Evans AJ; Pinder SE; Burrell HC; Ellis IO; Wilson AR J Med Screen; 2001; 8(2):86-90. PubMed ID: 11480449 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer screening by mammography in women aged under 50 years in Japan. Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440 [TBL] [Abstract][Full Text] [Related]
7. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project. Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530 [TBL] [Abstract][Full Text] [Related]
8. Mammographic screening: a key factor in the control of breast cancer. Tabár L; Smith RA; Vitak B; Yen MF; Chen TH; Warwick J; Myles JP; Duffy SW Cancer J; 2003; 9(1):15-27. PubMed ID: 12602763 [No Abstract] [Full Text] [Related]
9. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331 [TBL] [Abstract][Full Text] [Related]
10. Increasing incidence of and declining mortality from breast carcinoma. Trends in Malmö, Sweden, 1961-1992. Garne JP; Aspegren K; Balldin G; Ranstam J Cancer; 1997 Jan; 79(1):69-74. PubMed ID: 8988728 [TBL] [Abstract][Full Text] [Related]
11. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers. Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200 [TBL] [Abstract][Full Text] [Related]
12. Mammographic screening is dramatically changing age-incidence data for breast cancer. Hemminki K; Rawal R; Bermejo JL J Clin Oncol; 2004 Nov; 22(22):4652-3. PubMed ID: 15542818 [No Abstract] [Full Text] [Related]
13. Epidemiologic determinants of the mammographic parenchymal pattern. A population-based study within a mammographic screening program. Bergkvist L; Tabàr L; Bergström R; Adami HO Am J Epidemiol; 1987 Dec; 126(6):1075-81. PubMed ID: 3687919 [TBL] [Abstract][Full Text] [Related]
14. Edinburgh trial of screening for breast cancer: mortality at seven years. Roberts MM; Alexander FE; Anderson TJ; Chetty U; Donnan PT; Forrest P; Hepburn W; Huggins A; Kirkpatrick AE; Lamb J Lancet; 1990 Feb; 335(8684):241-6. PubMed ID: 1967717 [TBL] [Abstract][Full Text] [Related]
15. Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden. Hellquist BN; Duffy SW; Nyström L; Jonsson H J Med Screen; 2012 Mar; 19(1):14-9. PubMed ID: 22355181 [TBL] [Abstract][Full Text] [Related]
16. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897 [TBL] [Abstract][Full Text] [Related]
17. Breast carcinoma-in-situ: an emerging problem in Singapore. Chua CL; Tan PK; Chiang G; Soo KC; Low CH Singapore Med J; 1992 Aug; 33(4):383-5. PubMed ID: 1329232 [TBL] [Abstract][Full Text] [Related]
18. The role of mammographic parenchymal patterns in screening for carcinoma of the breast. Kalisher L; McLelland R Surg Gynecol Obstet; 1991 Jan; 172(1):81-8. PubMed ID: 1985351 [No Abstract] [Full Text] [Related]
19. Interval carcinomas in the Malmö Mammographic Screening Trial: radiographic appearance and prognostic considerations. Ikeda DM; Andersson I; Wattsgård C; Janzon L; Linell F AJR Am J Roentgenol; 1992 Aug; 159(2):287-94. PubMed ID: 1632342 [TBL] [Abstract][Full Text] [Related]
20. Mammographic density and urbanization: a population-based screening study. Viel JF; Rymzhanova R J Med Screen; 2012 Mar; 19(1):20-5. PubMed ID: 22337708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]